We read with great interest the thoughtful comments from Wang et al. [1] regarding our article, “Gaps in Glycaemic Monitoring and Underuse of Cardioprotective Glucose-Lowering Agents: Challenges of Inpatient Diabetes Care Identified by EFIM’s Diabesity Day Survey 2024″ [2]. We are grateful for their careful appraisal of our methodology and findings. We also appreciate the complementary insights provided by Zhang and Zhang [3], who expand the discussion towards multidisciplinary, technology-supported models of inpatient diabetes care.
